This proposal represents a continuation of our studies examining the structure-function of class I molecules of the MHC. Three issues will be addressed. The first will determine the role of the alpha3 domain of class I in the positive and negative selection of the T cell receptor (TcR) repertoire. We will utilize a laboratory engineered class I molecule, LQ3, which is the Ld in the alpha1, alpha2, TM, and cytoplasmic domains but derives its alpha3 domain from Q7b. Our published and preliminary data demonstrates that LQ3 binds Ld restricted peptides and is recognized by CD8 independent but not CD8 dependent cytotoxic T lymphocytes (CTL). The expression of LQ3 in C3H transgenic (TG) animals does not allow for the generation of cytomegalovirus (MCMV) specific Ld-restricted CTL, nor does it permit complete negative selection of anti-Ld alloreactive CTL. We will generate TG mice that express a TcR for Ld-MCMV and mate these animals to existing C3H.Ld and C3H.LQ3 TG mice to follow the fate of such cells. The failure of CTL to recognize LQ3 is presumably due to the inability of CD8 to interact with its ligand in the Q7 alpha3 domain. We will use a variety of CD8 <-> class I binding assays to characterize this defect. The second issue will address the relationship between low affinity (1o) and high affinity (2o) receptor alloreactive CTL. We will utilize the TcRs from a representative clone of each of these CTL to generate TcR TG mice. This will allow us to characterize the precursor-product relationship between such clones with regard to receptor avidity, CD8 expression, lymphokine secretion, and dependence of CD4 T helper activity. The third issue will focus on Qa-2 as an antigen presenting molecule. We will determine the TcR V gene usage of CTL specific for Q6 and Q7, the 2 major Qa-2 encoded antigens. We will determine the sequence of the Q6 gene, which is the major target molecule for Qa-2 specific CTL and establish whether these Qa molecules present a limited array of peptides.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI013111-20
Application #
2059954
Study Section
Experimental Immunology Study Section (EI)
Project Start
1976-08-01
Project End
1998-07-31
Budget Start
1996-08-01
Budget End
1998-07-31
Support Year
20
Fiscal Year
1996
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
Ungchusri, T; Kettman, J R; Forman, J (1997) Interaction of 2C T cells with a hybrid Ld molecule bearing an alpha 3 domain derived from the class IB molecule, Qa-2. Scand J Immunol 46:41-50
DeCloux, A; Woods, A S; Cotter, R J et al. (1997) Dominance of a single peptide bound to the class I(B) molecule, Qa-1b. J Immunol 158:2183-91
Brown, C R; Hunter, C A; Estes, R G et al. (1995) Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis. Immunology 85:419-28
Soloski, M J; DeCloux, A; Aldrich, C J et al. (1995) Structural and functional characteristics of the class IB molecule, Qa-1. Immunol Rev 147:67-89
Aldrich, C J; DeCloux, A; Woods, A S et al. (1994) Identification of a Tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen. Cell 79:649-58
Dick, L R; Aldrich, C; Jameson, S C et al. (1994) Proteolytic processing of ovalbumin and beta-galactosidase by the proteasome to a yield antigenic peptides. J Immunol 152:3884-94
Teitell, M; Holcombe, H; Cheroutre, H et al. (1993) The alpha 3 domain of the Qa-2 molecule is defective for CD8 binding and cytotoxic T lymphocyte activation. J Exp Med 178:2139-45
Lowen, L C; Aldrich, C J; Forman, J (1993) Analysis of T cell receptors specific for recognition of class IB antigens. J Immunol 151:6155-65
Aldrich, C J; Waltrip, R; Hermel, E et al. (1992) T cell recognition of QA-1b antigens on cells lacking a functional Tap-2 transporter. J Immunol 149:3773-7
Cassell, D; Forman, J (1991) Two roles for CD4 cells in the control of the generation of cytotoxic T lymphocytes. J Immunol 146:3-10

Showing the most recent 10 out of 32 publications